PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Clinical trial NCT05096481 · RECRUITING
Trial details
- NCT number
- NCT05096481
- Sponsor
- Nationwide Children's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-18
- Primary completion
- 2028-06-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.